|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.92 USD | +0.22% |
|
-0.23% | +24.46% |
| Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
| Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
On January 5, 2022, Catalent, Inc. announced that John R. Chiminski, Chair, will transition into the role of Executive Chair effective July 1, 2022. Mr. Chiminski will continue to serve as Chair of the Company's Board of Directors.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.46% | 10.1B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
CATALENT, INC. 
